Abstract
Group based Quantitative Structure Activity Relationship (GQSAR) was developed for thirty (4-keto-phenoxy) methyl biphenyl-4-sulfonamides which exhibit aggrecanase-1 enzyme inhibitory activity. This enzyme is involved in osteoarthritis. The data is divided into training and test sets, where the latter is used for validating the model. Substitution in the R1 position plays a major role when compared to substitution in R2 position. The former position is influenced by two descriptors, namely electrotopological and connectivity indices. R2 position is influenced by radius of gyration. The statistical parameters for the training set (r2 = 0.80, r2adj = 0.77, q2 = 0.69, F-ratio = 26.80 and standard error = 0.24) and the predicted r2 (r2 test =0.95) are satisfactory. Docking of the compounds with aggrecanase-1 enzyme showed that there is a strong negative correlation between the binding energy and aggrecanase -1 inhibitory activity. Compounds with the carbonyl substitution interact with the S'1 pocket which is needed for enhanced activity. The two methodologies described here can help in lead optimization.
Keywords: Aggrecanase, binding energy, docking, electrotopological descriptor, GQSAR, radius of gyration, biphenyl-4-sulfonamides, osteoarthritis, gyration, aggrecanase-1 enzyme
Medicinal Chemistry
Title:Computational Approaches to Improve Aggrecanase-1 Inhibitory Activity of (4-keto) Phenoxy) Methyl Biphenyl-4-sulfonamide: Group Based QSAR and Docking Studies
Volume: 8 Issue: 4
Author(s): Ponnurengam Malliappan Sivakumar, Naga Vignesh Selvaraj, G. Ramesh, J. Mohanapriya, Veluchamy Prabhawathi and Mukesh Doble
Affiliation:
Keywords: Aggrecanase, binding energy, docking, electrotopological descriptor, GQSAR, radius of gyration, biphenyl-4-sulfonamides, osteoarthritis, gyration, aggrecanase-1 enzyme
Abstract: Group based Quantitative Structure Activity Relationship (GQSAR) was developed for thirty (4-keto-phenoxy) methyl biphenyl-4-sulfonamides which exhibit aggrecanase-1 enzyme inhibitory activity. This enzyme is involved in osteoarthritis. The data is divided into training and test sets, where the latter is used for validating the model. Substitution in the R1 position plays a major role when compared to substitution in R2 position. The former position is influenced by two descriptors, namely electrotopological and connectivity indices. R2 position is influenced by radius of gyration. The statistical parameters for the training set (r2 = 0.80, r2adj = 0.77, q2 = 0.69, F-ratio = 26.80 and standard error = 0.24) and the predicted r2 (r2 test =0.95) are satisfactory. Docking of the compounds with aggrecanase-1 enzyme showed that there is a strong negative correlation between the binding energy and aggrecanase -1 inhibitory activity. Compounds with the carbonyl substitution interact with the S'1 pocket which is needed for enhanced activity. The two methodologies described here can help in lead optimization.
Export Options
About this article
Cite this article as:
Malliappan Sivakumar Ponnurengam, Vignesh Selvaraj Naga, Ramesh G., Mohanapriya J., Prabhawathi Veluchamy and Doble Mukesh, Computational Approaches to Improve Aggrecanase-1 Inhibitory Activity of (4-keto) Phenoxy) Methyl Biphenyl-4-sulfonamide: Group Based QSAR and Docking Studies, Medicinal Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157340612801216247
DOI https://dx.doi.org/10.2174/157340612801216247 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective
Current Pharmacogenomics and Personalized Medicine Interleukin-1β Increases Release of Endothelin-1 and Tumor Necrosis Factor as Well as Reactive Oxygen Species by Peripheral Leukocytes During Experimental Subarachnoid Hemorrhage
Current Neurovascular Research Administration of Ethanolic Extract of Ocimum Basilicum Leaves Attenuates Depression like Behavior in the Rats Sensitized by Ovalbumin
Current Nutrition & Food Science Airway Remodeling: Effect of Current and Future Asthma Therapies
Current Respiratory Medicine Reviews Restoration of the Immune Balance by Autologous Bone Marrow Transplantation in Juvenile Idiopathic Arthritis
Current Stem Cell Research & Therapy Photochemical Degradation of Hyperforin
Letters in Organic Chemistry Neuromodulation of Memory Formation and Extinction
Current Neurovascular Research γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Induction of Labour for Maternal Request: An Observational Study of Maternal and Fetal Outcomes
Reviews on Recent Clinical Trials Efficacy of Celecoxib Adjunct Treatment on Bipolar Disorder: Systematic Review and Meta-Analysis
CNS & Neurological Disorders - Drug Targets The Modern Spectrum of Rhabdomyolysis: Drug Toxicity Revealed by Creatine Kinase Screening
Current Drug Safety Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design Prospective Clinical Applications of CRF Peptide Antagonists
Current Molecular Pharmacology ISATIN: New Hope Against Convulsion
Central Nervous System Agents in Medicinal Chemistry Word Forms of Modern Japanese Sound Symbolic Words Not Listed in Dictionaries
Neuroscience and Biomedical Engineering (Discontinued) Involvement of L-Carnitine in Cellular Metabolism: Beyond Acyl-CoA Transport
Mini-Reviews in Medicinal Chemistry Inhibition of Tau Aggregation in Cell Models of Tauopathy
Current Alzheimer Research Designing Peptidomimetics
Current Topics in Medicinal Chemistry Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators
Current Computer-Aided Drug Design